Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tactile Systems TechnologyTCMD +2.32%65 Equity-to-Asset is 0.80 as of Mar. 2026, which is 10% above its 10-year median of 0.73. GuruFocus rates TCMD with a GF Score™ of 65/100 and a GF Value™ of $18.53 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Tactile Systems Technology ranks better than 75.88% on this metric.
Tactile Systems Technology (NAS:TCMD) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Tactile Systems Technology Equity-to-Asset Related Terms
Tactile Systems Technology Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TCMD vs CBLL, CERS, CTKB: Equity-to-Asset Comparison
For the Medical Devices subindustry, Tactile Systems Technology's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tactile Systems Technology Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tactile Systems Technology's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Tactile Systems Technology's Equity-to-Asset falls into.
Tactile Systems Technology Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Tactile Systems Technology's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tactile Systems Technology (TCMD) has a Equity-to-Asset of 0.80 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Tactile Systems Technology and its competitors. This is 10% above median its historical median of 0.73. Over the past decade, Tactile Systems Technology's Equity-to-Asset has ranged from 0.46 to 0.85. According to the industry distribution chart, Tactile Systems Technology ranks #206 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 24.1%.
Is Tactile Systems Technology's Equity-to-Asset too high?
Tactile Systems Technology's current Equity-to-Asset of 0.80 is 10% above median its 10-year median of 0.73. Over the past 10 years, this metric has ranged from a low of 0.46 to a high of 0.85. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Tactile Systems Technology's value of 0.80 is 25% above this industry median. Based on the distribution chart, Tactile Systems Technology ranks #206 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Tactile Systems Technology has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tactile Systems Technology's Equity-to-Asset compare to CBLL and CERS?
According to the Medical Devices & Instruments industry distribution chart, Tactile Systems Technology ranks #206 out of 854 companies for Equity-to-Asset. This places Tactile Systems Technology in the top 24% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.64. Tactile Systems Technology's value of 0.80 is 25% above this benchmark. Historically, Tactile Systems Technology's own Equity-to-Asset has ranged from 0.46 to 0.85 over the past decade. While the company's 10-year median is 0.73 vs. the industry median of 0.64, Tactile Systems Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tactile Systems Technology's current Equity-to-Asset of 0.80 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Tactile Systems Technology and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tactile Systems Technology's current Equity-to-Asset is 0.80, which is 10% above median its own 10-year median of 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tactile Systems Technology stock overvalued right now?
Based on GuruFocus' analysis, Tactile Systems Technology (TCMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $18.53, compared to a current price of $29.50 — trading 59.2% above its estimated fair value. The current Equity-to-Asset is 0.80, which is 10% above median its 10-year median of 0.73 and 25% above the Medical Devices & Instruments industry median of 0.64. Tactile Systems Technology's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Tactile Systems Technology (TCMD), the current Equity-to-Asset is 0.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tactile Systems Technology (TCMD) Overvalued in 2026?
Based on GuruFocus' analysis, Tactile Systems Technology stock appears to be overvalued.
The current stock price of $29.50 is trading 59.2% above its estimated GF Value™ of $18.53.
GuruFocus considers Tactile Systems Technology to be Significantly Overvalued.
Key valuation signals for TCMD:
Equity-to-Asset: 0.80 (10% above median its 10-year median of 0.73)
GF Value™: $18.53 vs. price of $29.50 (59.2% above fair value)
Industry Position: 25% above the Medical Devices & Instruments median (#206 of 854)
No single metric tells the full story. See the TCMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
65GF Score
Get the complete analysis for TCMD
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TCMD has been successfully added to your 
